Adrian Percy Joins Hi Fidelity Genetics Board of Directors

Adrian Percy Joins Finistere Ventures as CTO

Finistere Expands Tech Leadership and Adds Presence in Research Triangle, NC — Arama Kukutai Interviews Adrian Percy to Discuss His New Role

Industry luminary Adrian Percy, PhD, the former head of R&D for the Crop Science Division of Bayer, recently joined Finistere Ventures as Chief Technology Officer.

In his new role, he will provide strategic, technical and regulatory guidance for current portfolio companies. He will also support Finistere’s continued investment efforts, working with the team to identify and evaluate potential opportunities.

He will be joining the Boards of two Finistere-backed companies, BioLumic and Hi Fidelity Genetics, and will play a pivotal role in helping shape their ongoing research and development strategies, as well as supporting their partnership and commercialization efforts.

Read his interview with Arama Kukutai of Finistere Ventures, here.